推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

MOLECULAR THERAPY

2023年6月最新SCI影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 MOL THER最新评论:作为青椒来说,连个电脑也买不起。可是有的某些人学术水平不怎么地,但是经费如潮水般用不完。每天都绞尽脑汁怎么花钱,像版面费... (2021-04-25)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


MOLECULAR THERAPY期刊基本信息Hello,您是该期刊的第127238位访客

基本信息 登录收藏
期刊名字MOLECULAR THERAPYMOLECULAR THERAPY

MOL THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.8
54人评分
我要评分

声誉
9.6

影响力
8.1

速度
9.1

期刊ISSN1525-0016
微信扫码收藏此期刊
E-ISSN1525-0024
2022-2023最新影响因子
(数据来源于搜索引擎)
12.4 点击查看影响因子趋势图
实时影响因子 截止2023年9月27日:6.812
2022-2023自引率3.20%点击查看自引率趋势图
五年影响因子12.6
h-index 158
CiteScore
CiteScoreSJRSNIPCiteScore排名
17.903.4251.720
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q18 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Genetics
Q112 / 328
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q16 / 156
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q19 / 171
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Biology
Q125 / 380

期刊简介Molecular Therapy is the leading international journal for research on the development of molecular and cellular therapeutics to correct genetic and acquired diseases, including but not limited to research on gene transfer and editing, vector development and design, stem cell manipulation, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials.
期刊官方网站http://www.nature.com/mt/index.html
期刊投稿网址https://www.editorialmanager.com/MOLECULAR-THERAPY
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足MOLECULAR THERAPY的语言要求,还能让MOLECULAR THERAPY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被MOLECULAR THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式NATURE PUBLISHING GROUP, 75 VARICK ST, 9TH FLR, NEW YORK, USA, NY, 10013-1917
出版商Cell Press
涉及的研究方向医学-生物工程与应用微生物
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份2000
年文章数 239点击查看年文章数趋势图
Gold OA文章占比88.39%
研究类文章占比:
文章 ÷(文章 + 综述)
89.12%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY
类别:SCIE
Q18/156
学科:GENETICS & HEREDITY
类别:SCIE
Q14/171
学科:MEDICINE, RESEARCH & EXPERIMENTAL
类别:SCIE
Q18/136
中科院《国际期刊预警
名单(试行)》名单
2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2021年01月发布的2020版:不在预警名单中
中科院SCI期刊分区
2022年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区1区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
4区4区1区
GENETICS & HEREDITY
遗传学
1区3区1区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区4区1区
中科院SCI期刊分区
2021年12月基础版
大类学科小类学科Top期刊综述期刊
医学 1区1区4区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
1区2区1区
GENETICS & HEREDITY
遗传学
2区3区1区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区4区1区
中科院SCI期刊分区
2021年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
4区1区1区
GENETICS & HEREDITY
遗传学
1区3区1区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区4区1区
中科院SCI期刊分区
2020年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
生物工程与应用微生物
4区3区1区
GENETICS & HEREDITY
遗传学
1区3区1区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区4区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D
平均审稿速度网友分享经验:
平均1月
平均录用比例网友分享经验:
较难
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在MOLECULAR THERAPY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 MOLECULAR THERAPY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 MOLECULAR THERAPY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
MOLECULAR THERAPY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE BIOTECHNOLOGY39971.90
    TRENDS IN BIOTECHNOLOGY19531.30
    BIOTECHNOLOGY ADVANCES16127.10
    PLANT BIOTECHNOLOGY JOURNAL9619.20
    CRITICAL REVIEWS IN BIOTECHNOLOGY7917.50
    METABOLIC ENGINEERING10115.70
    CANCER GENE THERAPY809.30
    Microbial Cell Factories809.50
    Biotechnology for Biofuels7515.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE570830
    BIOMEDICINE & PHARMACOTHERAPY422755
    Frontiers in Pharmacology419957
    Frontiers in Immunology384386
    JOURNAL OF ETHNOPHARMACOLOGY375933
    Frontiers in Oncology358596
    Theranostics304783
    International Journal of Nanomedicine289856
    CANCER LETTERS289204
    Molecular Medicine Reports285997
  •  

    MOLECULAR THERAPY MOLECULAR THERAPY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma

    Author: Yang, Yi-Bin; Wu, Cai-Yuan; Wang, Xu-Yan; Deng, Jia; Cao, Wen-Jie; Tang, Yun-Zhi; Wan, Chao-Chao; Chen, Zhi-Tian; Zhan, Wan-Yu; Shan, Hong; Kuang, Dong-Ming; Wei, Yuan
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 105-118. DOI: 10.1016/j.ymthe.2022.09.019
        PubMed      DOI
    2.NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-KB-NFAT5 complex during septic immunosuppression

    Author: Xu, Jiqian; Gao, Chenggang; He, Yajun; Fang, Xiangzhi; Sun, Deyi; Peng, Zhekang; Xiao, Hairong; Sun, Miaomiao; Zhang, Pei; Zhou, Ting; Yang, Xiaobo; Yu, Yuan; Li, Ruiting; Zou, Xiaojing; Shu, Huaqing; Qiu, Yang; Zhou, Xi; Yuan, Shiying; Yao, Shanglong; Shang, You
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 154-173. DOI: 10.1016/j.ymthe.2022.08.023
        PubMed      DOI
    3.MAP7D2 reduces CD8+cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer

    Author: Wu, Qian; Yue, Xiao; Liu, Huashan; Zhu, Yaxi; Ke, Haoxian; Yang, Xin; Yin, Shi; Li, Zhihao; Zhang, Yunfeng; Hu, Tuo; Lan, Ping; Wu, Xianrui
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 90-104. DOI: 10.1016/j.ymthe.2022.09.001
        PubMed      DOI
    4.CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma

    Author: Wang, Guoqing; Zhang, Zongliang; Zhong, Kunhong; Wang, Zeng; Yang, Nian; Tang, Xin; Li, Hexian; Lu, Qizhong; Wu, Zhiguo; Yuan, Boyang; Zheng, Meijun; Cheng, Ping; Tong, Aiping; Zhou, Liangxue
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 134-153. DOI: 10.1016/j.ymthe.2022.08.021
        PubMed      DOI
    5.A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity

    Author: Shi, Wenqiang; Lv, Liangyin; Liu, Nan; Wang, Hui; Wang, Yang; Zhu, Wen; Liu, Zexin; Zhu, Jianwei; Lu, Huili
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 66-77. DOI: 10.1016/j.ymthe.2022.08.016
        PubMed      DOI
    6.Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma

    Author: Liu, Xiaoyu; Zhou, Jingying; Wu, Haoran; Chen, Shufen; Zhang, Lingyun; Tang, Wenshu; Duan, Liang; Wang, Ying; McCabe, Eleanor; Hu, Mengying; Yu, Zhuo; Liu, Hanzhuang; Choi, Chung Hang Jonathan; Sung, Joseph Jao-yiu; Huang, Leaf; Liu, Rihe; Cheng, Alfred Sze-lok
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 119-133. DOI: 10.1016/j.ymthe.2022.09.012
        PubMed      DOI
    7.NAMPT is a metabolic checkpoint of IFNy-producing CD4+T cells in lupus nephritis

    Author: Li, Mengyuan; Lai, Yimei; Chen, Binfeng; Guo, Chaohuan; Zhou, Mianjing; Zhao, Siyuan; Wang, Shuyi; Li, Jin; Yang, Niansheng; Zhang, Hui
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 193-210. DOI: 10.1016/j.ymthe.2022.09.013
        PubMed      DOI
    8.PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice

    Author: Li, Kaiqun; Chen, Yuhui; Lin, Yihuang; Zhang, Guangyan; Su, Jianwen; Wu, Xiaohu; Cheng, Caiyu; Wang, Yutian; Yu, Bin; Zhang, Xianrong
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 174-192. DOI: 10.1016/j.ymthe.2022.09.006
        PubMed      DOI
    9.Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system

    Author: Huang, Xinbo; Wang, Mingxia; Wu, Xia; Zou, Yanfen; Xu, Jinming; Cao, Congcong; Ma, Qian; Yu, Bo; Liu, Yuchen; Gui, Yaoting
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 260-268. DOI: 10.1016/j.ymthe.2022.10.009
        PubMed      DOI
    10.Balancing activation and co-stimulation of CAR tunes signaling dynamics and enhances therapeutic potency

    Author: Duan, Yanting; Chen, Jiangqing; Meng, Xianhui; Liu, Longwei; Shang, Kai; Wu, Xiaoyan; Wang, Yajie; Huang, Zihan; Liu, Houyu; Huang, Yanjie; Zhou, Chun; Gao, Xiaofei; Wang, Yingxiao; Sun, Jie
    Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 35-47. DOI: 10.1016/j.ymthe.2022.08.018
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共5条 (包含回复)

我来分享

    关闭窗口

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2023 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451